Evaluation of a high-sensitivity turbidimetric immunoassay for serum C-reactive protein: Application to the study of longitudinal changes throughout normal pregnancy

Clinical Chemistry and Laboratory Medicine

Volumn 43, Issue 3, 2005, Pages 308-313

  Bertran, Núria ^a   Camps, Jordi ^a   Fernández Ballart, Joan ^b   Murphy, Michelle M ^b   Arija, Victoria ^b   Ferré, Natàlia ^a   Tous, Mònica ^a   Joven, Jorge ^a  

^a HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

C reactive protein; Inflammation; Method evaluation; Pregnancy

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ERROR; EVALUATION; FEMALE; HEMOLYSIS; HUMAN; HYPERLIPIDEMIA; IMMUNOASSAY; JAUNDICE; LONGITUDINAL STUDY; PARAPROTEINEMIA; PREGNANCY; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; SENSITIVITY ANALYSIS; TURBIDIMETRY; WEIGHT GAIN;

EID: 17044395149     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2005.053     Document Type: Article

References (30)

1. Pickup JC, Crook MA. Is type 2 DM a disease of the innate immune system? Diabetologia 1998;41:1241-8.
2. Pickup JC, Mattock MB, Chusney GD, Burt D. NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X. Diabetologia 1997;40:1286-92.
3. Festa A, D'Agostino Jr R, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome. Circulation 2000; 102:42-7.
4. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-Reactive protein in healthy subjects: associations with obesity, insulin resistance, ant endothelial dysfunction. Arterioscler Thromb Vasc Biol 1999;19:972-8.
5. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
6. Lagrand WK, Visser CA, Hermens WT, Niessen HW, Verheught FW, Wolbink GJ, et al. C-Reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation 1999;100:96-102.
7. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-Reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000;342:836-43.
8. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men [erratum appears in N Engl J Med 1997;337:356]. N Engl J Med 1997;336:973-9.
9. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998;97:425-8.
10. Ridker PM, Buring JE, Shih J, Matias M, Hennekens CH. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 1998;98:731-3.
11. Roberts JM. Endothelial dysfunction in preeclampsia. Semin Reprod Endocrinol 1998;16:5-15.
12. Catalano PM. Obesity and pregnancy - the propagation of a vicious cycle? [editorial]. J Clin Endocr Metab 2003; 88:3505-6.
13. Retnakaran R, Hanley AJ, Raif N, Connelly PW, Sermer M, Zinman B. C-Reactive protein and gestational diabetes: the central role of maternal obesity. J Clin Endocr Metab 2003;88:3507-12.
14. Wolf M, Sandler L, Hsu K, Vossen-Smirnakis K, Ecker JL, Thadhani R. First-trimester C-reactive protein and subsequent gestational diabetes. Diabetes Care 2003; 26:819-24.
15. Tjoa ML, van Vugt JM, Go AT, Blankenstein MA, Oudejans CB, van Wijk U. Elevated C-reactive protein levels during first trimester of pregnancy are indicative of preeclampsia and intrauterine growth restriction. J Reprod Immunol 2003;59:29-37.
16. Wolf M, Kettyle E, Sandler L, Ecker JL, Roberts J, Thadhani R. Obesity and preeclampsia: the potential role of inflammation. Obstet Gynecol 2001;98:757-62.
17. Rifai N, Ridker PM. High-sensitivity C-reactive protein: a novel and promising marker of coronary heart disease. Clin Chem 2001;47:403-11.
18. Simó JM, Joven J, Clivillé X, Sans T. Automated latex agglutination immunoassay of serum ferritin with a centrifugal analyzer. Clin Chem 1994;40:625-29.
19. Murphy MM, Scott JM, McPartlin JM, Fernandez-Ballart JD. The pregnancy-related decrease in fasting plasma homocysteine is not explained by folic acid supplementation, hemodilution, or a decrease in albumin in a longitudinal study. Am J Clin Nutr 2002;76:614-19.
20. Ferré N, Camps J, Prats E, Girona J, Gómez F, Heras M, et al. Impaired vitamin E status in patients with parenchymal liver cirrhosis: relationships with lipoprotein compositional alterations, nutritional factors, and oxidative susceptibility of plasma. Metabolism 2002; 51:609-15.
21. Martin RF. General Deming regression for estimating systematic bias and its confidence interval in method-comparison studies. Clin Chem 2000;46:100-4.
22. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;i:307-10.
23. Roberts WL, Sedrick R, Moulton L, Spencer A, Rifai N. Evaluation of four automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Clin Chem 2000;46:461-8.
24. Roberts WL, Moulton L, Law TC, Farrow G, Cooper-Anderson M, Savory J, Rifai N. Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001;47:418-25.
25. Hamwi A, Vukovich T, Wagner O, Rumpold H, Spies R, Stich M, Langecker C. Evaluation of turbidimetric high-sensitivity C-reactive protein assays for cardiovascular risk estimation. Clin Chem 2001;47:2044-6.
26. De BK, Smith LG, Owen WE, Roberts WL. Performance characteristics of an automated high-sensitivity C-protein assay on the Dimension RXL analyzer. Clin Chim Acta 2002;323:151-5.
27. Ledue TB, Rifai N. Preanalytic and analytic sources of variations in C-reactive protein measurement: implications for cardiovascular disease risk assessment. Clin Chem 2003;49:1258-71.
28. Keski-Nisula L, Kirkinen P, Ollikainen M, Saarikoski S. C-Reactive protein in uncomplicated parturients delivered by cesarean section. Acta Obstet Gynecol Scand 1997; 76:862-7.
29. Hvilsom GB, Thorsen P, Jeune B, Bakketeig LS. C-Reactive protein: a serological marker for preterm delivery? Acta Obstet Gynecol Scand 2002;81:424-9.
30. Ramsay JE, Ferrell WR, Crawford L, Wallace MA, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways. J Clin Endocrinol Metab 2002;87:4231-7.